EUDAW
EUDA Health Holdings LimitedNASDAQ
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
—
Beta
0.16
52W High
$0.18
52W Low
$0.02
50-Day MA
$0.00
200-Day MA
$0.00
Dividend Yield
—
Profit Margin
5.17%
Forward P/E
—
PEG Ratio
—
About EUDA Health Holdings Limited
EUDA Health Holdings Limited is a dynamic biotechnology firm committed to developing cutting-edge therapies targeting dermatological and chronic health conditions. The company emphasizes scientific excellence and the integration of advanced technologies to address critical unmet medical needs, supported by a strategically prioritized pipeline of innovative products. With a seasoned leadership team focused on enhancing patient outcomes, EUDA is well-positioned to capitalize on growth opportunities in the evolving healthcare landscape.
Fundamentals
| Revenue (TTM) | $5.16M |
| Gross Profit (TTM) | $1.16M |
| EBITDA | $-1.99M |
| Operating Margin | -37.00% |
| Return on Equity | 0.00% |
| Return on Assets | -63.90% |
| Revenue/Share (TTM) | $2.80 |
| Book Value | $-2.00 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 60.20% |
| Shares Outstanding | 0 |
| Float | $1.17M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Data last updated: 4/21/2026